These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23910691)

  • 1. Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis.
    Rabenhorst A; Christopeit B; Leja S; Gerbaulet A; Kleiner S; Förster A; Raap U; Wickenhauser C; Hartmann K
    J Allergy Clin Immunol; 2013 Nov; 132(5):1234-1237.e7. PubMed ID: 23910691
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis.
    Rossini M; Adami S; Zanotti R; Viapiana O; Idolazzi L; Biondan M; Gatti D
    J Allergy Clin Immunol; 2014 Mar; 133(3):933-5. PubMed ID: 24439083
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 23910691.
    Rabenhorst A; Hartmann K
    J Allergy Clin Immunol; 2014 Mar; 133(3):935-6. PubMed ID: 24439082
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic mastocytosis associated with severe osteoporosis in a male patient.
    Gil-Diaz A; Delgado-Martinez JR; Suarez-Ortega S; Rivero-Vera JC; Lorenzo-Rivero JA; Betancor-Leon P
    Intern Med J; 2013 Apr; 43(4):461-2. PubMed ID: 23551312
    [No Abstract]   [Full Text] [Related]  

  • 5. Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
    Papadaki HA; Tsatsanis C; Christoforidou A; Malliaraki N; Psyllaki M; Pontikoglou C; Miliaki M; Margioris AN; Eliopoulos GD
    J Bone Miner Metab; 2004; 22(6):577-87. PubMed ID: 15490268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic mastocytosis: bone impact].
    Spivacow FR; Sarli M; Nakutny R
    Medicina (B Aires); 2012; 72(3):201-6. PubMed ID: 22763156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two patients with osteoporosis: initial presentation of systemic mastocytosis.
    Donker ML; Bakker NA; Jaspers WJ; Verhage AH
    J Bone Miner Metab; 2008; 26(2):199-202. PubMed ID: 18301978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
    Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
    Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenia and osteoporosis in children.
    Cassidy JT
    Clin Exp Rheumatol; 1999; 17(2):245-50. PubMed ID: 10342055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
    Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis.
    Rovner AJ; Miller RS
    Pediatrics; 2008 Oct; 122(4):907-8; author reply 908-9. PubMed ID: 18829822
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteoporosis associated with pulmonary silicosis in an equine bone fragility syndrome.
    Arens AM; Barr B; Puchalski SM; Poppenga R; Kulin RM; Anderson J; Stover SM
    Vet Pathol; 2011 May; 48(3):593-615. PubMed ID: 21097716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased leukotriene E4 excretion in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: pathologic long bone fracture in a patient with systemic mastocytosis.
    King JJ; Crawford EA; Iwenofu OH; Fox EJ
    Clin Orthop Relat Res; 2007 Jun; 459():263-9. PubMed ID: 17327804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerotic vascular disease may be associated with osteoporosis or osteopenia in postmenopausal women: a preliminary study.
    Gupta G; Aronow WS
    Arch Gerontol Geriatr; 2006; 43(2):285-8. PubMed ID: 16426688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoporosis as a first manifestation of systemic mastocytosis. Study of 6 cases].
    Sallés M; Holgado S; Navarro JT; Ribera JM; Riera E; Millà F; Tena X
    Med Clin (Barc); 2007 Feb; 128(6):216-8. PubMed ID: 17335726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic mastocytosis].
    Fain O; Stirnemann J; Lortholary O
    Rev Prat; 2005 Oct; 55(15):1629-36. PubMed ID: 16334197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone metabolic disease associated with celiac disease].
    Bai JC; Mauriño EC
    Gastroenterol Hepatol; 1997 Apr; 20(4):209-16. PubMed ID: 9280617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic mastocytosis--rare cause of pathologic vertebral fracture].
    Stamm AC; Burbelko M; Rominger M
    Rofo; 2008 Jan; 180(1):57-9. PubMed ID: 17968773
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study.
    Rolla D; Ballanti P; Marsano L; Bianchi G; Messa P; Paoletti E; Cannella G
    Transplantation; 2006 Mar; 81(6):915-21. PubMed ID: 16570017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.